029HO14062 GILLESPY

Print/PDF
Registration Name DE-SU GILLESPY-ET
Registration Number HOUSA000063449626
Primary NAAB Code 029HO14062
Secondary Code(s) 629HO14026, 529HO14062, 530HO14062, 531HO14062, 532HO14062, 533HO14062
Status Inactive
Controller Name ABS Global (29)
Date of Birth 6/29/2007
aAa 312
DMS 234,123
GFI 9.1%
Genetic Codes * BY TV TL TD
Haplotypes HH1T, HH2T, HH3T, HH4T, HH5T, HH6T, HCD-T
Sire SANDY-VALLEY BOLTON-ET
MGS PICSTON SHOTTLE-ET
Beta Casein A1A2
Kappa Casein AA
Beta Lactoglobulin AA
INDEXES
NM$ -174, 93% R CM$ -209
NM Percentile 14% FM$ -87
GTPI 2309 GM$ -238
PRODUCTION TRAITS
30885 Dtrs 7413 herds 17 % US 99% R
Milk 1143 Fat, % -12 , -0.22%
SCS 2.86, 99% R Protein, % 7 , -0.11%
Feed Saved -95 , 62% R Milking Speed 6.2 , 81% R
Health & Fertility
Productive Life -2.0      99% R Mastitis -0.8      96% R
Heifer Livability 1.1       88% R Metritis -2.8      91% R
Livability -1.0      96% R D. Abom 0.4      96% R
DPR -3.7      99% R Ketosis -1.3      91% R
HCR -0.8      97% R R. Placenta -0.3      92% R
CCR -4.4      99% R Milk Fever 0.0      80% R
SCR -        -
Calving Traits
Sire CE 2.0      99% R 35934 Obs
Daughter CE 2.5      98% R 6210 Obs, 16682 Dtrs
Sire SB 4.0      98% R 36511 Obs
Daughter SB 5.5      98% R 5677 Obs, Dtrs
Gestation Length 2.3      99% R 1058 Obs, 10886 Dtrs
Early First Calving -1.2      98% R 1080 Obs, 4919 Dtrs

CDCB December 2025; Base of Evaluation: HO

* Individual bull owners may test for more recessives

Composites HA 12/2025
16503 Dtrs 4574 herds 98% R
PTA Type 0.56 UDC 0.10
FLC 0.76 BWC -0.22
Linear Traits
Stature 0.68
Tall
Strength 0.07
Strong
Body Depth 0.78
Deep
Dairy Form 1.46
Open
Rump Angle 1.74
Sloped
Thurl Width 1.16
Wide
Rear Legs-Side View 1.07
Curved
Rear Legs-Rear View 0.75
Straight
Foot Angle 0.69
Steep
Feet & Legs Score 0.92
High
F.U. Attachment -0.47
Weak
Rear Udder Height 0.58
High
Rear Udder Width 0.30
Wide
Udder Cleft 1.05
Strong
Udder Depth -0.29
Deep
Front Teat Placement 1.31
Close
Rear Teat Placement 1.74
Close
Teat Length 0.30
Long
-2
0
2

CDCB December 2025; Base of Evaluation: HO